In 2010, the American Care Act was signed and opened the health insurance market to many individuals who were not previously eligible for insurance policies (Health & Human Services, 2019). Prior to the ACA, US citizens may have been eligible for insurance if they worked full time and their employer carried the benefit, they were over 65 and could enroll in Medicare, lived under the poverty line and could enroll in Medicaid, or paid insurance companies directly for coverage if you met the criteria and did not have any pre-existing conditions. Throughout Europe and parts of Asia, developed nations have models of universal healthcare in which every citizen is given a healthcare policy no matter their employment status. This dates back to post World War II when the US helped rebuild the many nations involved by implementing the Marshall Plan; among other things, this Plan outlined a way for all citizens of their respective countries to receive the proper medical attention they needed. Stateside, businesses worked with the Chamber of Commerce and major healthcare groups like The American Medical Association to keep insurance plans in the hands of private companies and out of the scope of the government.

Still today the matter of private versus government-issued healthcare is a polarizing issue. Where many feel that healthcare is a fundamental right and that a government allowing the health of its populace to flounder is irresponsible of the nation, many others feel that bringing the government into the healthcare conversation will only worsen the amount and type of care our citizenry receives. The propaganda of “socialized medicine” and the thought of “big brother” telling the American people what care they can or cannot receive is not too far off from the privatized model, where a small group of multi-billion-dollar insurance companies ultimately decide what level of care you receive, forcing patients and doctors to fight for testing and procedures that the companies refuse to pay. More information on either side of the argument would only benefit the American people, but, unfortunately, people will only believe what they wish to be true and the fight for a universal healthcare model will continue to rage on.


Gene Therapy: A Pro-Con Analysis

Only recently becoming recently marketed, gene therapy has been researched for over two decades. Comprised of ten thin layers that function together to give animal life sight through light detection. These layers, much like any other tissue in the body, perform their specific functions when their associated genes encode proteins necessary for use. Even the mutation of one gene can disrupt various life functions, including degenerative blindness when a gene of the eye is involved. In December 2018, the Food and Drug Administration approved the first-ever gene therapy, Luxturna, to treat the specific genetic mutation found in patients with a rare vision abnormality called Leber’s Congenital Amaurosis, (FDA, 2017). Although the potential for the expansion of gene therapy is promising, with it comes risks and significant costs, both physically and financially.

Continue reading “Gene Therapy: A Pro-Con Analysis”